Corrie Program Lead: Francoise Marvel, MD
Johns Hopkins Hospital
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease
Dr. Francoise Marvel is a Cardiology Fellow at Johns Hopkins Hospital and the Ciccarone Center for the Prevention of Cardiovascular disease. Dr. Marvel is Co-Founder of Corrie Health a health technology company for cardiovascular disease prevention and a recipient of the EmPOWERED To Serve Urban Health Accelerator™ grant. Through this opportunity she serves as an ambassador impacting gaps in health equity through advocacy, policy, education and social change. Dr. Marvel also serves as member of the American Heart Association Young Hearts Board in Baltimore, Maryland.
Dr. Marvel has a clinical interest in cardiovascular disease prevention, health technology, health equity, precision medicine, and implementing innovative healthcare transformational technology to improve population health. To build a foundation in healthcare technology innovation and quality improvement, Dr. Marvel pursued fellowships in Technology Innovation and Healthcare Quality Improvement at Johns Hopkins.
Dr. Marvel early on recognized the opportunity to improve the healthcare system and delivery approach by understanding the problems patients faced in being engaged, empowered, and having access to resources to manage their own health. These insights, along with caring for patients and families at the bedside, inspired the Corrie program to take shape. In 2016 in Cupertino, California alongside Apple and Johns Hopkins colleagues Drs. Seth Martin, MD and Matthias Lee, PhD – Corrie was created.
Over the next year, Dr. Marvel helped co-lead the Myocardial Infarction COmbined device Recovery Enhancement (MiCORE) multisite study evaluating Corrie Health among acute myocardial patients. Preliminary results show a signal for decreased risk of 30-day readmission, higher engagement, and feasibility in acute care settings. Currently, Dr. Marvel aims to expand our understanding of the role of health technology, machine learning, and big data through ongoing testing and scaling of the Corrie Health platform for cardiovascular disease prevention.
Dr. Marvel attributes the momentum of Corrie to the dedicated multidisciplinary team, patients, families, and the support of the American Heart Association who answer the call for action to improve health equity and cardiovascular health in our communities. Since its beginning, Dr. Marvel and the Corrie team have been recognized by Apple, Uber, American Heart Association, American College of Cardiology Innovation Challenge, American College of Physicians for healthcare transformation, European Society of Cardiology, Maryland Innovation Initiative, Stanford Medicine X, and Prevention magazine. Dr. Marvel’s ongoing commitment to patients and innovative discovery has been recognized through a Golden Heart award given by patients, Johns Hopkins Medicine Clinical Excellence award, the Howard K. Rathbun Award for clinical excellence, and the Stanley Blumenthal award for research.